Literature DB >> 19964641

Variability of action potential duration in pharmacologically induced long QT syndrome type 1.

Caroline L Ring1, Salim F Idriss, Wanda Krassowska Neu.   

Abstract

Long QT Syndrome (LQTS) is a congenital disorder associated with life-threatening arrhythmias. LQT1, a type of LQTS affecting the slow delayed rectifier potassium current, shows a higher incidence of arrhythmia associated with sympathetic stimulation than other types of LQTS. LQT1 patients show increased variability of repolarization with epinephrine infusion, as measured from the 12-lead ECG. We investigate the variability of repolarization measured as action potential duration (APD) in the rabbit left ventricle: how APD variability is affected by pacing rate, transmural location, LQT1 induced by chromanol 293b, and epinephrine infusion. Chromanol preferentially changes APD variability in the midwall. Infusing epinephrine returns the variability to near-control levels. These results differ substantially from clinical studies and show the need for further study.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19964641      PMCID: PMC4288588          DOI: 10.1109/IEMBS.2009.5334105

Source DB:  PubMed          Journal:  Conf Proc IEEE Eng Med Biol Soc        ISSN: 1557-170X


  15 in total

Review 1.  The M cell: its contribution to the ECG and to normal and abnormal electrical function of the heart.

Authors:  C Antzelevitch; W Shimizu; G X Yan; S Sicouri; J Weissenburger; V V Nesterenko; A Burashnikov; J Di Diego; J Saffitz; G P Thomas
Journal:  J Cardiovasc Electrophysiol       Date:  1999-08

2.  The restitution portrait: a new method for investigating rate-dependent restitution.

Authors:  Soma S Kalb; Hana M Dobrovolny; Elena G Tolkacheva; Salim F Idriss; Wanda Krassowska; Daniel J Gauthier
Journal:  J Cardiovasc Electrophysiol       Date:  2004-06

3.  Spatial heterogeneity of the restitution portrait in rabbit epicardium.

Authors:  Ann M Pitruzzello; Wanda Krassowska; Salim F Idriss
Journal:  Am J Physiol Heart Circ Physiol       Date:  2006-11-22       Impact factor: 4.733

4.  A MULTICHANNEL FIBER-OPTIC MAPPING SYSTEM FOR INTRAMURAL RECORDING OF CARDIAC ACTION POTENTIALS.

Authors:  A M Pitruzzello; W Krassowska; A J Lam; S F Idriss
Journal:  IFMBE Proc       Date:  2005

5.  A low-cost high-efficiency fiber-optic coupler for recording action potentials within the myocardial wall.

Authors:  Salim F Idriss; Ann M Pitruzzello
Journal:  IEEE Trans Biomed Eng       Date:  2006-08       Impact factor: 4.538

6.  Potassium and calcium current blocking properties of the novel antiarrhythmic agent H 345/52: implications for proarrhythmic potential.

Authors:  G J Amos; C Abrahamsson; G Duker; L Hondeghem; M Palmer; L Carlsson
Journal:  Cardiovasc Res       Date:  2001-02-01       Impact factor: 10.787

7.  Response of beat-by-beat QT variability to sympathetic stimulation in the LQT1 form of congenital long QT syndrome.

Authors:  Kazuhiro Satomi; Wataru Shimizu; Hiroshi Takaki; Kazuhiro Suyama; Takashi Kurita; Naohiko Aihara; Shiro Kamakura
Journal:  Heart Rhythm       Date:  2005-02       Impact factor: 6.343

8.  Cellular basis for the ECG features of the LQT1 form of the long-QT syndrome: effects of beta-adrenergic agonists and antagonists and sodium channel blockers on transmural dispersion of repolarization and torsade de pointes.

Authors:  W Shimizu; C Antzelevitch
Journal:  Circulation       Date:  1998-11-24       Impact factor: 29.690

9.  Potentiation of E-4031-induced torsade de pointes by HMR1556 or ATX-II is not predicted by action potential short-term variability or triangulation.

Authors:  G Michael; J Dempster; K A Kane; S J Coker
Journal:  Br J Pharmacol       Date:  2007-10-29       Impact factor: 8.739

10.  Adrenaline reveals the torsadogenic effect of combined blockade of potassium channels in anaesthetized guinea pigs.

Authors:  G Michael; K A Kane; S J Coker
Journal:  Br J Pharmacol       Date:  2008-05-19       Impact factor: 8.739

View more
  1 in total

Review 1.  Minimizing repolarization-related proarrhythmic risk in drug development and clinical practice.

Authors:  Attila S Farkas; Stanley Nattel
Journal:  Drugs       Date:  2010-03-26       Impact factor: 9.546

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.